Hunt and Hess scale and modified Fisher scale (also searched with alternate eponym and descriptive spellings, ICD-10: I60.9) represent foundational clinical and radiological stratification systems utilized globally in neurocritical care and neurosurgery to evaluate patients presenting with aneurysmal subarachnoid hemorrhage (aSAH)1,2. The Hunt and Hess scale, originally introduced in 1968, grades the severity of a patient's clinical presentation based on symptoms such as headache, level of alertness, nuchal rigidity, and focal neurological deficits, correlating strongly with overall survival and surgical morbidity. Concurrently, the modified Fisher scale refines initial radiological assessment by quantifying the presence and thickness of subarachnoid blood clots on non-contrast computed tomography (CT) scans alongside intraventricular blood extension, providing high predictive accuracy for the development of delayed cerebral ischemia (DCI) and secondary neurological deterioration2.

Etiology & Risk Factors

  • Aneurysmal Rupture: The overwhelming majority of non-traumatic subarachnoid hemorrhages stem from the rupture of intracranial saccular ("berry") aneurysms, predominantly located at bifurcations of the Circle of Willis (most commonly the anterior communicating artery, middle cerebral artery, and posterior communicating artery).
  • Genetics & Connective Tissue Disorders: Inherited conditions such as autosomal dominant polycystic kidney disease (ADPKD), Ehlers-Danlos syndrome type IV, Marfan syndrome, and pseudoxanthoma elasticum significantly increase structural arterial wall weakness and aneurysm formation.
  • Environmental & Lifestyle Modifiers: Active cigarette smoking, chronic hypertension, excessive alcohol consumption, and sympathomimetic drug use (such as cocaine or amphetamines) serve as major modifiable risk factors accelerating arterial wall degradation and triggering acute rupture.
  • Demographic Predisposition: A higher baseline incidence and altered risk profile are observed in female patients and individuals aged 40 to 60 years, with female sex identified as an independent risk factor for worse outcomes and secondary complications following aneurysmal hemorrhage2.

Pathophysiology

The pathophysiological sequence begins with the sudden, high-pressure rupture of an intracranial aneurysm, forcing arterial blood directly into the subarachnoid space. This acute extravasation causes an immediate spike in intracranial pressure (ICP), transient global cerebral ischemia, and meningeal irritation. As blood degrades within the subarachnoid cisterns and ventricles, hemoglobin breakdown products—including free iron, oxyhemoglobin, and reactive oxygen species—induce direct endothelial injury, smooth muscle cell contraction, and localized neuroinflammation. This biochemical milieu promotes severe vasoconstriction of major cerebral arteries, manifesting clinically as delayed cerebral ischemia (DCI) typically between days 4 and 14 post-hemorrhage. Furthermore, impaired cerebrospinal fluid (CSF) reabsorption through arachnoid granulations blocked by blood clots frequently results in communicating or obstructive hydrocephalus, compounding elevated ICP and worsening cerebral perfusion pressure.

Hunt and Hess scale and modified Fisher scale — Pathophysiological Cascade & Clinical Flowchart 1 Intracranial Aneurysm Rupture Sudden high-pressure arterial extravasation into the subarachnoid space causing acute intracranial hypertension 2 Blood Distribution & Ischemia Cascade Extravasated blood breakdown products and thick cisternal clot burden triggering severe cerebral vasospasm and neuroinflammation 3 Vascular & Parenchymal Injury Development of delayed cerebral ischemia, cytotoxic edema, and elevated intracranial pressure threatening neural tissue 4 Clinical Presentation Manifestation of severe headache, focal neurological deficits, altered consciousness, and high clinical grade on neurosurgical assessment 5 Therapeutic Intervention Microsurgical or endovascular aneurysm obliteration coupled with neurocritical care monitoring and vasospasm prophylaxis

Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients classically present with an abrupt, excruciating "thunderclap" headache, frequently described as the worst headache of their lives, often accompanied by sudden nausea, projectile vomiting, brief loss of consciousness, and photophobia.
  • Physical Examination & Named Clinical Signs: Examination commonly reveals pronounced nuchal rigidity and positive meningeal signs (such as Kernig's and Brudzinski's signs) due to chemical meningeal irritation from blood. High-grade presentations may exhibit focal neurological deficits, cranial nerve palsies (particularly cranial nerve III palsy with pupillary dilation in posterior communicating artery aneurysms), hemiparesis, decerebrate or decorticate posturing, and profound coma.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationDigital subtraction angiography (DSA) demonstrating the exact anatomical location, size, and neck morphology of the ruptured intracranial aneurysm, supplemented by non-contrast head CT confirming subarachnoid blood distribution.
Laboratory PanelComplete blood count, comprehensive metabolic panel, coagulation profile (PT/INR, aPTT), and cardiac biomarkers to evaluate for neurogenic stress cardiomyopathy and systemic electrolyte disturbances (e.g., syndrome of inappropriate antidiuretic hormone secretion or cerebral salt wasting causing hyponatremia).
Imaging / Radiology (X-ray, US, CT, MRI)Non-contrast head CT demonstrating hyperdense blood within the basal cisterns, sulci, and ventricles; CT angiography (CTA) for rapid non-invasive vascular profiling; Transcranial Doppler (TCD) ultrasonography daily to monitor cerebral blood flow velocities and screen for developing vasospasm.
ECG / Histopathology / ProceduralElectrocardiogram frequently showing diffuse T-wave inversion, prominent U waves, and QT prolongation indicative of acute catecholamine surge; lumbar puncture reserved for CT-negative cases to analyze CSF for xanthochromia.

Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Hunt and Hess Grade IAsymptomatic, minimal headache, or slight nuchal rigidity. (Favorable prognosis; prompt angiographic workup and elective repair).
Hunt and Hess Grade IIModerate to severe headache, nuchal rigidity, no neurological deficit except cranial nerve palsy. (Moderate prognosis; intensive monitoring and definitive aneurysm securing).
Hunt and Hess Grade IIIDrowsiness, confusion, or mild focal neurological deficit. (Guarded prognosis; aggressive critical care and external ventricular drainage if hydrocephalus is present).
Hunt and Hess Grade IVStupor, moderate to severe hemiparesis, early decerebrate rigidity or vegetative disturbances. (Poor prognosis; urgent surgical evaluation and intensive ICP management).
Hunt and Hess Grade VDeep coma, decerebrate posturing, moribund appearance. (Very poor prognosis; high mortality, requiring multidisciplinary goals-of-care discussion).
Modified Fisher Scale Grade 0No subarachnoid blood or intraventricular blood detected on initial head CT. (Lowest risk of delayed cerebral ischemia).
Modified Fisher Scale Grade 1Thin subarachnoid blood clot distributed sparsely in cisterns/sulci; no intraventricular blood. (Low risk of delayed cerebral ischemia).
Modified Fisher Scale Grade 2Thin subarachnoid blood clot with associated intraventricular blood in both lateral ventricles. (Intermediate risk of delayed cerebral ischemia).
Modified Fisher Scale Grade 3Thick subarachnoid blood clot localized in cisterns/sulci; no intraventricular blood. (High risk of delayed cerebral ischemia and secondary vasospasm).
Modified Fisher Scale Grade 4Thick subarachnoid blood clot localized in cisterns/sulci with bilateral intraventricular blood extension. (Highest risk of delayed cerebral ischemia and poor functional outcome).

Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Primary Intracerebral HemorrhageSudden focal neurological deficits with prominent parenchymal hematoma on neuroimaging, often linked to chronic hypertension or amyloid angiopathy rather than cisternal subarachnoid blood.
Reversible Cerebral Vasoconstriction Syndrome (RCVS)Presents with recurrent thunderclap headaches; neuroimaging shows multifocal segmental cerebral arterial constriction without primary subarachnoid hemorrhage on initial CT.
Bacterial or Viral MeningitisSubacute onset of fever, headache, and neck stiffness evolving over days; CSF analysis reveals marked leukocytosis, elevated protein, and low glucose, without blood.
Cerebral Venous Sinus ThrombosisHeadache accompanied by signs of intracranial hypertension and focal seizures; magnetic resonance venography demonstrates filling defects within dural venous sinuses.

Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Immediate management focuses on airway protection, adequate oxygenation, and tight blood pressure control (systolic blood pressure maintained below 160 mmHg prior to aneurysm securing to prevent rebleeding while maintaining cerebral perfusion pressure).
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing): Administration of oral nimodipine at 60 mg every 4 hours for 21 days is mandatory to reduce poor outcomes from cerebral vasospasm. Blood pressure management during vasospasm phases utilizes induced hypertension with crystalloids or colloids under invasive arterial line monitoring. Electrolyte balance must be strictly monitored to prevent hyponatremia.
  • Surgical / Interventional Indications: Definitive securing of the ruptured aneurysm should be performed as early as possible (ideally within 24–48 hours) via endovascular coil embolization or open microsurgical clipping. Placement of an external ventricular drain (EVD) is indicated for patients presenting with acute obstructive hydrocephalus and decreased level of consciousness.

Complications & Prognosis

  • Acute Complications: Rebleeding (associated with extremely high mortality if occurring before aneurysm securing), acute obstructive hydrocephalus, neurogenic stunned myocardium, and life-threatening intracranial pressure surges.
  • Delayed Complications: Delayed cerebral ischemia (DCI) secondary to vasospasm, chronic normal-pressure hydrocephalus requiring permanent shunt placement, hyponatremia, and persistent cognitive or neuropsychological deficits.
  • Prognosis: Overall prognosis is dictated heavily by the presenting Hunt and Hess grade and modified Fisher grade. High clinical grades (IV and V) and high radiological clot volumes (Modified Fisher 3 and 4) carry significantly elevated morbidity and mortality rates, necessitating protracted neurorehabilitation and aggressive critical care intervention.